• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无法获得丁丙诺啡治疗作为使用被转移丁丙诺啡的风险因素。

Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine.

机构信息

Department of Psychiatry, University of Kentucky College of Medicine, Lexington, KY, United States.

出版信息

Drug Alcohol Depend. 2012 Dec 1;126(3):379-83. doi: 10.1016/j.drugalcdep.2012.05.025. Epub 2012 Jun 15.

DOI:10.1016/j.drugalcdep.2012.05.025
PMID:22704124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3449053/
Abstract

BACKGROUND

As buprenorphine prescribing has increased in the United States so have reports of its diversion. The study purpose was to examine frequency and source of and risk factors for diverted buprenorphine use over a 6-month period in an Appalachian community sample of prescription opioid abusers.

METHODS

There were 503 participants at baseline; 471 completed the 6-month follow-up assessment. Psychiatric disorders and demographic, drug use, and social network characteristics were ascertained at baseline and follow-up. Multivariable logistic regression was used to determine the predictors of diverted buprenorphine use over the 6-month period.

RESULTS

Lifetime buprenorphine use "to get high" was 70.1%. Nearly half (46.5%) used diverted buprenorphine over the 6-month follow-up period; among these persons, 9.6% and 50.6% were daily and sporadic (1-2 uses over the 6-months) users, respectively. The most common sources were dealers (58.7%) and friends (31.6%). Predictors of increased risk of use of diverted buprenorphine during the 6-month follow-up included inability to access buprenorphine treatment (AOR: 7.31, 95% CI: 2.07, 25.8), meeting criteria for generalized anxiety disorder, and past 30 day use of OxyContin, methamphetamine and/or alcohol.

CONCLUSIONS

These results suggest that improving, rather than limiting, access to good quality affordable buprenorphine treatment may be an effective public health strategy to mitigate buprenorphine abuse. Future work should evaluate why more persons did not attempt to access treatment, determine how motivations change over time, and how different motivations affect diversion of the different buprenorphine formulations.

摘要

背景

随着美国丁丙诺啡处方量的增加,其被滥用和转移的报告也越来越多。本研究的目的是在阿巴拉契亚地区社区样本中,检测在过去 6 个月中,处方类阿片类药物滥用者丁丙诺啡被滥用和转移的频率、来源和风险因素。

方法

在基线时有 503 名参与者;其中 471 名完成了 6 个月的随访评估。在基线和随访时确定了精神疾病和人口统计学、药物使用和社会网络特征。多变量逻辑回归用于确定 6 个月期间丁丙诺啡被滥用和转移的预测因素。

结果

一生中“为了兴奋”而使用丁丙诺啡的比例为 70.1%。近一半(46.5%)的人在 6 个月的随访期间使用了被转移的丁丙诺啡;其中,9.6%和 50.6%分别为每日和偶尔使用者(6 个月内使用 1-2 次)。最常见的来源是经销商(58.7%)和朋友(31.6%)。在 6 个月的随访期间,增加使用被转移的丁丙诺啡的风险因素包括无法获得丁丙诺啡治疗(AOR:7.31,95%CI:2.07,25.8)、符合广泛性焦虑障碍标准以及过去 30 天内使用过奥施康定、冰毒和/或酒精。

结论

这些结果表明,改善而不是限制高质量负担得起的丁丙诺啡治疗的获取,可能是减轻丁丙诺啡滥用的有效公共卫生策略。未来的工作应评估为什么更多的人没有尝试获得治疗,确定动机如何随时间变化,以及不同的动机如何影响不同丁丙诺啡制剂的转移。

相似文献

1
Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine.无法获得丁丙诺啡治疗作为使用被转移丁丙诺啡的风险因素。
Drug Alcohol Depend. 2012 Dec 1;126(3):379-83. doi: 10.1016/j.drugalcdep.2012.05.025. Epub 2012 Jun 15.
2
Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.肯塔基州进入基于惩教机构的药物治疗的成年人中丁丙诺啡转移使用情况的特征分析
Drug Alcohol Depend. 2020 Mar 1;208:107837. doi: 10.1016/j.drugalcdep.2020.107837. Epub 2020 Jan 9.
3
The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.阿片类激动剂治疗的可及性与阿片类药物滥用之间的复杂关系:以捷克大规模滥用丁丙诺啡为例。
Harm Reduct J. 2018 Dec 4;15(1):60. doi: 10.1186/s12954-018-0268-0.
4
Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review.美国丁丙诺啡转用的范围、动机和结果:范围综述。
Subst Use Misuse. 2023;58(5):685-697. doi: 10.1080/10826084.2023.2177972. Epub 2023 Feb 20.
5
Buprenorphine in the United States: Motives for abuse, misuse, and diversion.丁丙诺啡在美国:滥用、误用和转移的动机。
J Subst Abuse Treat. 2019 Sep;104:148-157. doi: 10.1016/j.jsat.2019.07.005. Epub 2019 Jul 12.
6
Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians.丁丙诺啡的转移和滥用:来自治疗患者和医生全国调查的结果。
Drug Alcohol Depend. 2012 Jan 1;120(1-3):190-5. doi: 10.1016/j.drugalcdep.2011.07.019. Epub 2011 Aug 21.
7
Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System.丁丙诺啡透皮给药系统的滥用与误用分析
J Pain. 2016 Jun;17(6):745-52. doi: 10.1016/j.jpain.2016.02.015. Epub 2016 Mar 18.
8
When Prescribing Isn't Enough - Pharmacy-Level Barriers to Buprenorphine Access.当处方开具不足时——丁丙诺啡获取的药房层面障碍
N Engl J Med. 2020 Aug 20;383(8):703-705. doi: 10.1056/NEJMp2002908.
9
Assessing Motivations for Nonprescribed Buprenorphine Use Among Rural Appalachian Substance Users.评估阿巴拉契亚农村地区药物使用者非处方使用丁丙诺啡的动机。
J Addict Med. 2023;17(1):95-100. doi: 10.1097/ADM.0000000000001050. Epub 2022 Aug 30.
10
Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.阿片类药物使用者中丁丙诺啡/纳洛酮的非法使用。
J Addict Med. 2011 Sep;5(3):175-80. doi: 10.1097/ADM.0b013e3182034e31.

引用本文的文献

1
A scoping review of social determinants of health's impact on substance use disorders over the life course.生命历程中健康社会决定因素对物质使用障碍影响的范围综述。
J Subst Use Addict Treat. 2024 Nov;166:209484. doi: 10.1016/j.josat.2024.209484. Epub 2024 Aug 15.
2
Anxiety treatment of methamphetamine-dependent patients with buprenorphine: A randomized, double-blind, clinical trial.丁丙诺啡用于甲基苯丙胺依赖患者的焦虑症治疗:一项随机、双盲临床试验。
Tzu Chi Med J. 2022 Jun 14;35(1):89-94. doi: 10.4103/tcmj.tcmj_297_21. eCollection 2023 Jan-Mar.
3
Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use.患者报告的丁丙诺啡处方配药问题及非法使用动机。
Drug Alcohol Depend Rep. 2022 Sep 8;5:100091. doi: 10.1016/j.dadr.2022.100091. eCollection 2022 Dec.
4
Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review.美国丁丙诺啡转用的范围、动机和结果:范围综述。
Subst Use Misuse. 2023;58(5):685-697. doi: 10.1080/10826084.2023.2177972. Epub 2023 Feb 20.
5
Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017-2019.2017-2019 年马萨诸塞州快速评估中吸毒人群中非致命性药物过量的流行情况及其相关因素。
Harm Reduct J. 2021 Aug 30;18(1):93. doi: 10.1186/s12954-021-00538-9.
6
Examining the Relationship between Social Connection and Opioid Misuse: A Systematic Review.探讨社会联系与阿片类药物滥用之间的关系:系统综述。
Subst Use Misuse. 2021;56(10):1493-1507. doi: 10.1080/10826084.2021.1936056. Epub 2021 Jun 17.
7
Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast.美国东北部非城市地区注射吸毒者使用多种药物的模式、背景及动机。
Int J Drug Policy. 2020 Nov;85:102934. doi: 10.1016/j.drugpo.2020.102934. Epub 2020 Sep 7.
8
Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.视频直接观察疗法干预使用移动健康应用程序在接受基于办公室的丁丙诺啡治疗的阿片类药物使用障碍患者中:一项试点随机对照试验的方案。
Addict Sci Clin Pract. 2020 Jul 31;15(1):30. doi: 10.1186/s13722-020-00203-9.
9
Longitudinal trends in nonmedical prescription opioid use in a cohort of rural Appalachian people who use drugs.农村阿巴拉契亚药物使用人群中,非医疗处方类鸦片类药物使用的纵向趋势。
Prev Med. 2020 Nov;140:106194. doi: 10.1016/j.ypmed.2020.106194. Epub 2020 Jul 9.
10
Leveraging black-market street buprenorphine pricing to increase capacity to treat opioid addiction, 2010-2018.利用黑市街头丁丙诺啡价格来提高治疗阿片类药物成瘾的能力,2010 - 2018年。
Prev Med. 2020 Aug;137:106105. doi: 10.1016/j.ypmed.2020.106105. Epub 2020 Apr 27.

本文引用的文献

1
Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.农村阿巴拉契亚地区吸毒者中首次非法使用毒品向首次注射吸毒的转变:横断面比较和回顾性生存分析。
Addiction. 2012 Mar;107(3):587-96. doi: 10.1111/j.1360-0443.2011.03635.x. Epub 2011 Oct 26.
2
Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians.丁丙诺啡的转移和滥用:来自治疗患者和医生全国调查的结果。
Drug Alcohol Depend. 2012 Jan 1;120(1-3):190-5. doi: 10.1016/j.drugalcdep.2011.07.019. Epub 2011 Aug 21.
3
Efficacy of continuing medical education to reduce the risk of buprenorphine diversion.继续教育在减少丁丙诺啡滥用风险中的效果。
J Subst Abuse Treat. 2011 Oct;41(3):321-9. doi: 10.1016/j.jsat.2011.04.008. Epub 2011 Jun 12.
4
Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience.在初级保健中使用丁丙诺啡对阿片类药物成瘾患者进行协作护理:五年经验。
Arch Intern Med. 2011 Mar 14;171(5):425-31. doi: 10.1001/archinternmed.2010.541.
5
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.经鼻吸食粉碎的丁丙诺啡与丁丙诺啡/纳洛酮片剂在阿片类药物滥用者中的药效学和药代动力学特征。
Addiction. 2011 Aug;106(8):1460-73. doi: 10.1111/j.1360-0443.2011.03424.x. Epub 2011 May 3.
6
Examining gender differences in substance use and age of first use among rural Appalachian drug users in Kentucky.考察肯塔基州农村阿巴拉契亚地区药物使用者中药物使用和首次使用年龄的性别差异。
Am J Drug Alcohol Abuse. 2011 Mar;37(2):98-104. doi: 10.3109/00952990.2010.540282. Epub 2010 Dec 10.
7
Post-marketing surveillance of methadone and buprenorphine in the United States.美国美沙酮和丁丙诺啡的上市后监测。
Pain Med. 2010 Jul;11(7):1078-91. doi: 10.1111/j.1526-4637.2010.00877.x. Epub 2010 Jun 8.
8
Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence.丁丙诺啡/纳洛酮复方片剂在高处方流行地区的转移。
J Addict Dis. 2009 Jul;28(3):226-31. doi: 10.1080/10550880903014767.
9
Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.马里兰州巴尔的摩市阿片类药物成瘾者对美沙酮和丁丙诺啡的滥用。
Am J Addict. 2009 Sep-Oct;18(5):346-55. doi: 10.3109/10550490903077820.
10
Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.基于办公室的丁丙诺啡/纳洛酮维持治疗的长期结果。
Drug Alcohol Depend. 2010 Jan 1;106(1):56-60. doi: 10.1016/j.drugalcdep.2009.07.013. Epub 2009 Aug 29.